Evidence map›Paper›PMID 32407190›Full record

ArticleMicrobial drug resistance (Larchmont, N.Y.)2020

Antimicrobial Resistance and Molecular Characterization of Gene Cassettes from Class 1 Integrons in

Mi Liu, Jie Ma, Wei Jia, Wanxiang Li

Open access · hybridAbstract read
In one paragraph

Article in Microbial drug resistance (Larchmont, N.Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Characterization of genetic context ofFrontiers in microbiology · 2025
    Article
  7. Prevalence of Antibiotic Resistance Determinants in Carbapenem-ResistantInternational journal of molecular and cellular medicine · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. EFFECT OFAfrican journal of infectious diseases · 2024
    Article
  12. Applied and environmental microbiology · 2023
    Article
  13. Article
  14. Article
  15. Antibiotic Resistance in Pseudomonas.Advances in experimental medicine and biology · 2022
    Article
  16. β-lactam Resistance inPathogens (Basel, Switzerland) · 2021
    Review
  17. Review
  18. First Report ofInfection and drug resistance · 2021
    Article
  19. Co-existence of blaPakistan journal of medical sciences
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mi LiuDepartment of Clinical Laboratory, Weifang People's Hospital, Weifang, Shandong, China.
Jie MaDepartment of Clinical Laboratory, Weifang People's Hospital, Weifang, Shandong, China.
Wei JiaDepartment of Clinical Laboratory, Weifang People's Hospital, Weifang, Shandong, China.
Wanxiang LiDepartment of Clinical Laboratory, Weifang People's Hospital, Weifang, Shandong, China.
Weifang People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the antibiotic-resistance phenotypes and molecularly characterized class 1 integron gene cassettes from 113

Indexed as

Anti-Bacterial AgentsChinaDNA, BacterialDrug Resistance, Multiple, BacterialHumansIntegronsMicrobial Sensitivity TestsOligopeptidesPhenotypePolymerase Chain ReactionPseudomonas aeruginosaSequence Analysis, DNAAnti-Bacterial AgentsDNA, BacterialOligopeptidessuccinyl-alanyl-alanyl-phenylalanine-4-nitroanilideantibiotics resistanceclass 1 integronsmolecular characterizationPseudomonas aeruginosa

Identifiers

PMID32407190
PMCPMC7307683
OpenAlexW3025707988

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.